Chemocentryx Stock Current Valuation
| CCXIDelisted Stock | USD 51.99 0.00 0.00% |
Valuation analysis of ChemoCentryx helps investors to measure ChemoCentryx's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that ChemoCentryx's price fluctuation is very steady at this time. Calculation of the real value of ChemoCentryx is based on 3 months time horizon. Increasing ChemoCentryx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ChemoCentryx is useful when determining the fair value of the ChemoCentryx stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ChemoCentryx. Since ChemoCentryx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ChemoCentryx Stock. However, ChemoCentryx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 51.99 | Real 37.95 | Hype 51.99 |
The real value of ChemoCentryx Stock, also known as its intrinsic value, is the underlying worth of ChemoCentryx Company, which is reflected in its stock price. It is based on ChemoCentryx's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ChemoCentryx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ChemoCentryx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ChemoCentryx helps investors to forecast how ChemoCentryx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ChemoCentryx more accurately as focusing exclusively on ChemoCentryx's fundamentals will not take into account other important factors: ChemoCentryx Company Current Valuation Analysis
ChemoCentryx's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ChemoCentryx Current Valuation | 3.45 B |
Most of ChemoCentryx's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChemoCentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, ChemoCentryx has a Current Valuation of 3.45 B. This is 75.98% lower than that of the Healthcare sector and 25.73% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 79.25% higher than that of the company.
ChemoCentryx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChemoCentryx's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ChemoCentryx could also be used in its relative valuation, which is a method of valuing ChemoCentryx by comparing valuation metrics of similar companies.ChemoCentryx is currently under evaluation in current valuation category among related companies.
ChemoCentryx Fundamentals
| Return On Equity | -46.96 | |||
| Return On Asset | -18.55 | |||
| Operating Margin | (353.17) % | |||
| Current Valuation | 3.45 B | |||
| Shares Outstanding | 70.03 M | |||
| Shares Owned By Insiders | 12.01 % | |||
| Shares Owned By Institutions | 84.39 % | |||
| Number Of Shares Shorted | 7.61 M | |||
| Price To Earning | 40.53 X | |||
| Price To Book | 10.04 X | |||
| Price To Sales | 97.66 X | |||
| Revenue | 37.28 M | |||
| Gross Profit | (51.07 M) | |||
| EBITDA | (127.6 M) | |||
| Net Income | (133.09 M) | |||
| Cash And Equivalents | 328.62 M | |||
| Cash Per Share | 4.61 X | |||
| Total Debt | 73.2 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 4.54 X | |||
| Book Value Per Share | 5.18 X | |||
| Cash Flow From Operations | (53.5 M) | |||
| Short Ratio | 4.89 X | |||
| Earnings Per Share | (0.94) X | |||
| Number Of Employees | 178 | |||
| Beta | 1.23 | |||
| Market Capitalization | 3.64 B | |||
| Total Asset | 78.16 M | |||
| Retained Earnings | (441.3 M) | |||
| Working Capital | 66.54 M | |||
| Current Asset | 72.03 M | |||
| Current Liabilities | 5.49 M | |||
| Z Score | 19.1 |
About ChemoCentryx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChemoCentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChemoCentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChemoCentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with ChemoCentryx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoCentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoCentryx will appreciate offsetting losses from the drop in the long position's value.Moving together with ChemoCentryx Stock
| 0.83 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.83 | NONOF | Novo Nordisk AS | PairCorr |
Moving against ChemoCentryx Stock
| 0.76 | WXIBF | WuXi Biologics | PairCorr |
| 0.76 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.64 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.56 | CSLLY | CSL | PairCorr |
| 0.52 | CMXHF | CSL Limited | PairCorr |
The ability to find closely correlated positions to ChemoCentryx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoCentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoCentryx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoCentryx to buy it.
The correlation of ChemoCentryx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoCentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoCentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoCentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in ChemoCentryx Stock
If you are still planning to invest in ChemoCentryx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChemoCentryx's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |